Building on the proven performance of the GORE® EXCLUDER® Device family, the conformable stent graft and innovative delivery system offer new levels of control when you need it most.

Continuing the pattern of performance

Zero type I and III endoleaks

Sub-study outcomes. One-year follow-up*,†

100% technical success

Sub-study outcomes. One-year follow-up*,†

98.6% freedom from aneurysm enlargement

Sub-study outcomes. One-year follow-up*,†

I am impressed with how well the device performed in the clinical study and appreciate the efforts of the investigators who contributed to this milestone.

– Robert Rhee, M.D., Chief of Vascular and Endovascular Surgery, Maimonides Medical Center, Brooklyn, New York , National Principal Investigator

* For these data points, a minimum of 66 patients were eligible for one year outcome analysis, meeting all follow-up requirements that included contrast enhanced CT’s. More than 66 patients were included in some data points, which can be confirmed in the Instructions for Use.

† 1-year follow-up. Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms. NLM Identifier: NCT02489539. Published July 3, 2015. Updated June 16, 2020. Accessed November 17, 2020. https://clinicaltrials.gov/ct2/show/NCT02489539

 

Featured Resources

Measurement Form with Anatomy

GORE® EXCLUDER® Conformable AAA Endoprosthesis, GORE® EXCLUDER® Iliac Branch Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis

PDF, 324.91 KB

GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System product logo